FDA Approves Smart Device for Accurate Placement of Epidural Injections

Omeq Medical’s EpiFinder — which assists physicians to accurately position an epidural needle for spinal anesthesia — has received regulatory clearance from the FDA.

The current technique — loss of resistance in the epidural space — has been used for epidurals since the 1920s and fails in up to 30 percent of patients, the company said.

EpiFinder is a single-use epidural placement device that integrates with the standard loss of resistance technique and monitors tissue resistance at the needle tip to accurately detect needle penetration into the epidural space.

A clinical study conducted by Omeq resulted in successful epidural blocks in all 31 patients in the study.

Related Topics